News | April 20, 2011

Application Helps Physicians Identify More Lung Nodules in Chest X-Rays

April 20, 2011 – A new study published in Radiology has demonstrated that using a bone suppression application with chest X-rays significantly increased the detection of lung nodules proven to be primary lung cancer. The study used Riverain Medical’s SoftView system. SoftView enhances chest imaging uses machine learning and image processing algorithms to suppress the ribs and clavicles that obscure nodules that may be early-stage lung cancer. The reader study, funded by Riverain Medical and conducted at Georgetown University in Washington, D.C., was led by Matthew Freedman, M.D., associate professor of Oncology at the Lombardi Comprehensive Cancer Center. The study consisted of fifteen radiologists analyzing 368 chest X-rays. The radiologists interpreted the standard chest X-ray to locate lung nodules and then reviewed the SoftView bone suppressed image. The authors concluded that “the radiologists using visualization software significantly increased their detection of lung cancers and benign nodules" than without this technology. In fact, 74 percent of the additional cancers found when reviewing the SoftView images were in hard-to-view areas with 70 percent or greater bone and nodule overlap. As a result, the program helped clinicians decide whether to suggest additional diagnostic testing including CT and lung biopsy. “Finding lung cancer at its earliest, most treatable stage is the key to the survival of this disease that claimed the lives of more than 150,000 Americans in 2010 alone,” said Steve Worrell, chief technology officer of Riverain Medical. “The publication of this peer-reviewed study confirms that SoftView allows physicians to identify more early-stage lung nodules under some of the most challenging conditions when using a chest X-ray.” The U.S. Food and Drug Administration (FDA) cleared the application in March 2010. , It is designed to increase the clarity of chest X-rays by suppressing bone. It can be applied to every chest X-ray in the hospital without specialized imaging equipment, changes in imaging protocols or additional radiation dose to the patient. Using advanced bone suppression and image enhancement algorithms, it automatically provides a soft tissue image for more confident image interpretations. “Clinical data has shown that the early detection of lung cancer can save lives,” said Diane Hirakawa, CEO and chairman of Riverain Medical. “It is encouraging to see a growing body of scientific work demonstrating the benefits of SoftView. Riverain Medical is committed to developing technology that can change the outcomes of patients by aiding in the detection of cancer at its earliest and most treatable stage.” For more information:

Related Content

3D Systems Announces On Demand Anatomical Modeling Service
Technology | Medical 3-D Printing | June 18, 2018
3D Systems announced availability of its new On Demand Anatomical Modeling Service. This new service provides a wide...
Metropolitan Washington Orthopaedic Practice Upgrades DR With Agfa DX-D 300s
News | Digital Radiography (DR) | June 15, 2018
Agfa announced that it has installed two DX-D 300 digital radiography (DR) solutions at the multi-office Centers for...
News | Remote Viewing Systems | June 14, 2018
International Medical Solutions (IMS) recently announced that the American College of Radiology (ACR) added IMS'...
Riverain Technologies Issued U.S. Patent for Vessel Suppression Technology
News | Computed Tomography (CT) | June 14, 2018
Riverain Technologies announced that the United States Patent and Trademark Office (USPTO) has awarded the company a...
Technology | Orthopedic Imaging | June 13, 2018
EOS imaging announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its hipEOS...
Wake Radiology Launches First Installation of EnvoyAI Platform
News | Artificial Intelligence | June 13, 2018
Artificial intelligence (AI) platform provider EnvoyAI recently completed their first successful customer installation...
PET/CT Changes Care for 59 Percent of Suspected Recurrent Prostate Cancer Cases
News | Prostate Cancer | June 13, 2018
A recently presented investigational clinical trial evaluated the impact of 18F fluciclovine positron emission...
Accuray TomoTherapy System Beneficial in Two Total Body Irradiation Studies
News | Radiation Therapy | June 13, 2018
Recently published data from two new studies demonstrate the benefits of Accuray’s TomoTherapy System in the delivery...
Women More Likely to Use Other Preventive Health Services Following Mammography
News | Mammography | June 13, 2018
Medicare beneficiaries who undergo breast cancer screening with mammography are more likely than unscreened women to...
Reduced hippocampal volume on MRI

This figure shows reduced hippocampal volume over the course of 6 years as seen on progressive volumetric analysis and also coronal MRI evaluations (arrows).Progressive volume loss in the mesial temporal lobe on MRI is a characteristic imaging feature of AD. This patient was a case of Alzheimer’s Dementia.


News | Neuro Imaging | June 12, 2018
According to a UCLA Medical Center study, a new technology shows the potential to help doctors better determine when...
Overlay Init